Adapting the Proteostasis Network to Ameliorate GABAA Receptor Folding Diseases

Abstract: Proteostasis deficiency in ion channels leads to a variety of ion channel diseases called channelopathies, which are often caused by excessive endoplasmic reticulum-associated degradation (ERAD) and inefficient membrane trafficking of mutant ion channels. We focus on proteostasis maintenance of gamma-aminobutyric acid type A (GABAA) receptors, the primary inhibitory ion channels in the mammalian central nervous system. Numerous epilepsy-associated missense mutations in the receptor subunits predispose them to rapid ERAD, reduce their cell surface expression, and cause loss of their function. We aimed to use small molecules to adapt the proteostasis network in the ER to restore the surface trafficking and function of such mutant receptors. Our screening assay from a structurally diverse FDA-approved drug library identified lead compounds that enhanced the surface expression of a number of trafficking-deficient mutant receptors. Furthermore, patch clamping electrophysiology showed that these lead compounds restored their function on the plasma membrane. Mechanistic studies revealed that they reduced the degradation by attenuating the ERAD pathway. In addition, they enhanced the folding of the mutant subunits by enhancing their interactions with major GABAA receptors-interacting chaperones. Both ERAD inhibition and folding enhancement contributed to the improved ER-to-Golgi trafficking efficiency of the mutant receptors. These compounds hold the promise to be further developed to ameliorate idiopathic epilepsy resulting from excessive GABAA receptor degradation.
Research:
Bio: David Mitzi is the Simon Family Professor at Duke University, with appointments to the Departments of Mechanical Engineering and Materials Science and ÌÇÐÄvlog¹Ù·½Èë¿Ú. He received his B.S. in Electrical Engineering and Engineering Physics from Princeton University (1985) and his Ph.D. in Applied Physics from Stanford University (1990). Prior to joining the faculty at Duke (2014), Dr. Mitzi spent 23 years at IBM’s Watson Research Center, where his focus was on the search for and application of new electronic materials, including organic-inorganic perovskites and inorganic materials for photovoltaic, LED, transistor and memory applications. For his final five years at IBM, he served as manager for the Photovoltaic Science and Technology Department, where he initiated/managed a multi-company program to develop a low-cost, high-throughput approach to deposit thin-film chalcogenide-based absorbers for high-efficiency photovoltaics. Dr. Mitzi has recently been elected a Materials Research Society (MRS) Fellow and named a Clarivate Analytics Highly Cited Researcher.


Maureen Tang joined the faculty of Chemical and Biological Engineering at Drexel University in fall 2014. She received her BS in Chemical Engineering from Carnegie Mellon University in 2007 and her PhD from the University of California, Berkeley in 2012. While at Berkeley, she received a NSF Graduate Research Fellowship, an NSF East Asia Pacific Summer Fellowship, and the Daniel Cubiciotti Student Award of the Electrochemical Society. Dr. Tang completed postdoctoral work at Stanford University and research internships at Kyoto University, the University of Dortmund, and DuPont. She is the recipient of a 2018 NSF CAREER award, the 2019 College of Engineering Early Career Research Award, and a 2018 Award for Excellence in Peer Review from the ACS PRF. Her research at Drexel develops materials, architectures and fundamental insight for electrochemical energy storage and conversion.






